A semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine.
Mainly used to treat bacterial infections of the skin. It can also be used to treat moderately severe bacterial infections involving the lung, bone, joint, stomach, blood, heart valve, and urinary tract. It is clinically effective against infections caused by staphylococci and streptococci species of Gram positive bacteria. May be used for surgical prophylaxis; if required metronidazole may be added to cover B. fragilis.
Remington-Davis Clinical Research, Columbus, Ohio, United States
HaEmek medical center, Afula, Israel
University of California, Irvine, Orange, California, United States
MemorialCare Center for Women at Miller Children's Hospital Long Beach and Long Beach Memorial Medical Center, Long Beach, California, United States
Erlanger Health System, Chattanooga, Tennessee, United States
Hospital das Clinicas Samuel Libanio, Pouso Alegre, Minas Gerais, Brazil
Hospital e Maternidade Santa Paula, Pouso Alegre, Minas Gerais, Brazil
Department of Otolaryngology, Rabin Medical Center, Petach Tikva, Israel
Toledo Children's Hospital, Toledo, Ohio, United States
Arkansas Children's Hospital, Little Rock, Arkansas, United States
Magee-Women's Hospital/University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
West Virginia University Hospital, Morgantown, West Virginia, United States
Hospital Italiano de Buenos Aires, Buenos Aires, Capital, Argentina
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.